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ABSTRACT
Punch biopsies of human skin were obtained 1 day after
irradiation with two minimal-erythema doses (MED) from
either a UVB light source or a Solar Simulator and incubated
in organ culture for 72 h. Organ culture fluids obtained at
24, 48 and 72 h were analyzed for collagenolytic activity and
for reactivity with antibodies to matrix metalloproteinase-1
(MMP-1; interstitial collagenase) and MMP-13 (collagenase-
3). High levels of collagenolytic activity were seen in organ
culture fluid from skin exposed to either light source. MMP-1
was strongly induced in parallel, increasing from less than 100
ng/ml in organ culture fluid from control skin to approxi-
mately 1.1 mg/ml in culture fluid from UV-treated skin.
Whereas most of the detectable MMP-1 in control culture
fluid was represented by the latent form of the enzyme,
approximately 50% of the enzyme was present as the active
form in organ culture fluid of UV-exposed skin. In contrast,
there was no detectable MMP-13 in control organ culture fluid
and very little change after UV exposure (less than 100 ng/ml
in both cases). Finally, neutralization studies with a blocking
antibody to MMP-1 removed 95 6 4% of the collagenolytic
activity in the organ culture fluid from UV-treated skin. These
findings strongly implicate MMP-1 rather than MMP-13 as
the major collagenolytic enzyme responsible for collagen dam-
age in photoaging.
INTRODUCTION
The matrix metalloproteinases (MMP) are a family of enzymes that
together have the capacity to degrade virtually every component of
the extracellular matrix (1,2). Although several MMP are expressed
in mammalian skin, only the three collagenolytic enzymes—i.e.
MMP-1 (interstitial collagenase), MMP-8 (neutrophil collagenase)
and MMP-13 (collagenase-3)—can degrade native, fibrillar Type-I
and Type-III collagen.
Studies conducted over the past several years have shown that
exposure of the skin to UV radiation results in the upregulation of
several different MMP, including those with collagenolytic activity
(3,4). The repeated upregulation of these collagen-degrading
enzymes over years or decades is thought to underlie the collagen
damage that is one of the hallmarks of photoaging. However, the
contribution of each of the individual collagenolytic enzymes to
the overall connective tissue destruction seen in severely photo-
damaged skin is not known. Recent studies suggest a limited role
for MMP-8 (5). Although this enzyme was induced by UV light, its
upregulation was minimal. Furthermore, the time course for MMP-
8 expression in UV-irradiated tissue did not correlate with the time
course for buildup of collagen fragments in the UV-exposed skin.
On the basis of these observations it was concluded that although
MMP-8 was present in the skin after UV irradiation, it probably
contributed little to the overall structural damage to collagen in
photoaging.
The present studies continue our effort to understand the role of
individual MMP in photoaging. Here we describe studies in which
expression and function of MMP-1 and MMP-13 were directly
compared in UV-treated skin. Our studies show that MMP-1 was
strongly induced by UV exposure, whereas MMP-13 was either
not detectable or detected at a very low level. Concomitant with
upregulation of MMP-1 was activation of the latent enzyme.
Finally, and most importantly, our studies show that neutralization
of MMP-1 removed virtually all the collagen-degrading activity
elaborated by UV-treated human skin. Taken together with our
previous observations (5), these studies suggest that MMP-1 is the
major collagenolytic enzyme responsible for collagen destruction
in severely photodamaged skin.
MATERIALS AND METHODS
Preparation of organ culture fluid from irradiated skin. Healthy adults
with light skin pigmentation (three female, three male; age range 25–45
years) were irradiated on the hip with light from four F36T12 ERE-VHO
tubes as described elsewhere (4). Wavelengths below 290 nm were
removed by a Kodacel TA401/407 filter (Eastman Kodak Co., Rochester,
NY). An IL1400 phototherapy radiometer and SED240/UVB/UV photo-
detector (International Light, Newbury, MA) were used to monitor
irradiation intensity. Power output distribution in the UV spectrum was
63% UVB (290–320 nm), 25% UVA2 (320–340 nm) and 12% UVA1
(340–400 nm). The UV dose that caused barely perceptible skin reddening
(minimal erythema dose [MED]) was determined for each subject as
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previously described (4). With this light source, wavelengths in the UVB
range of the spectrum are primarily responsible for enzyme induction.
In additional studies, three healthy adults (two female, one male; age
range 22–37 years) were exposed to light from a Solar Simulator. To
simulate solar radiation, a 450 W xenon arc lamp, filtered with a Schott
WG320 filter to remove wavelengths below 290 nm and coupled to a liquid
light guide, was used. The spectral output of this source was determined
with an OL754 spectroradiometer (Optronic Laboratories, Orlando, FL).
The UV spectrum for the xenon arc lamp was 0.00006% UVC, 6.6% UVB,
16.5% UVA2 and 76.8% UVA1. An IL 1440 phototherapy radiometer
and a SED240/UVB/UV photodetector (International Light) were used to
monitor the light output. As with the UVB light source, the UV dose that
caused barely perceptible skin reddening (1 MED) was determined for each
subject. With this light source, a combination of wavelengths in the UVB
and UVA1 ranges of the spectrum is primarily responsible for enzyme
induction.
Duplicate 4 mm punch biopsies of sun-protected (buttock) skin were
obtained from the subjects 1 day after exposure to UV irradiation (2 MED)
from either light source. The skin biopsies were cut into small pieces (6–8/
biopsy) and incubated for 72 h in 1.5 mL of Ca2þ-supplemented (1.4 mM
final concentration) keratinocyte basal medium (KBM) (MA Bioproducts,
Walkersville, MD). Incubation was at 378C under 5% CO2. Our previous
studies have demonstrated that these culture conditions preserve histolog-
ical structure and biochemical function of human skin for several days (6).
At the end of the incubation period, the culture fluid was clarified by low-
speed centrifugation and used as the enzyme source. The participation of
human subjects in this project was approved by the University of Michigan
Institutional Review Board, and all subjects provided written informed
consent before their inclusion in the study.
Purified human MMP and other reagents. Human MMP-1 and MMP-13
were obtained from Calbiochem (San Diego, CA). MMP-1 was purified
from human rheumatoid synovial fibroblasts as the proenzyme form, and
MMP-13 was obtained as a recombinant protein encompassing the
proenzyme 60 kDa form. Rabbit polyclonal IgG antibodies to MMP-1
(AB806) and MMP-13 (AB8114) were obtained from Chemicon In-
ternational (Temecula, CA). These antibodies were used in Western blotting
studies. A rabbit polyclonal IgG (R & D Systems, Minneapolis, MN) was
used as a control. In addition to these antibodies, a mouse monoclonal anti–
MMP-1 antibody with neutralizing activity (Ab-5; IM66) was obtained
from Oncogene Research Products (San Diego, CA).
Western blotting. Supernatant fluids from control or UV-exposed skin
were analyzed by Western blotting with rabbit polyclonal anti–MMP-1
or anti–MMP-13 antibodies. Purified MMP-1 and MMP-13 served as
standards. Samples were separated in 10% sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) under denaturing and
reducing conditions and transferred to nitrocellulose membranes. After
blocking with a 5% nonfat milk solution in Tris–buffered saline (TBS) at
48C overnight, membranes were incubated for 1 h at room temperature with
either of the rabbit polyclonal antibodies, diluted 1:6000 in 0.5% nonfat
milk–0.1% Tween-TBS (TTBS). Thereafter the membranes were washed
with TTBS and the bound antibodies detected using the Phototope-HRP
Western blot detection kit (New England Biolabs, Beverly, MA). The
Western blotting procedure has been described previously (7). Preliminary
studies revealed no detectable cross-reactivity between purified MMP-1 and
anti–MMP-13 antibodies or between purified MMP-13 and anti–MMP-1
antibodies.
Substrate-embedded enzymography. SDS-PAGE substrate-embedded
enzymography (zymography) was used to identify enzymes with col-
lagenase and gelatinase activities. Assays were carried out exactly as de-
scribed in a previous report (8). In brief, denatured but nonreduced culture
fluid samples were resolved in 7.5% SDS-PAGE gels prepared with the
incorporation of gelatin (1 mg/mL) or b-casein (1 mg/mL) before casting.
After electrophoresis, gels were washed twice for 15 min in 50 mM Tris
buffer containing 1 mM Ca2þ, 0.5 mM Zn2þ and 2.5% Triton X-100. The
gels were then incubated overnight in Tris buffer with 1% Triton X-100 and
stained the following day with Coomassie Brilliant Blue 250-R. After
destaining, zones of enzyme activity were detected as regions of negative
staining against the dark background. Volumes of 5–35 lL of undiluted
culture fluid were normally used for these assays; zones of activity were
proportional to the quantity of culture fluid used. Gelatin zymography is
useful for detection of MMP-2 (72 kDa gelatinase A) and MMP-9 (92 kDa
gelatinase B). MMP-13 can also be detected by gelatin zymography as a
zone of hydrolysis beneath the active MMP-2 band. b-Casein zymography
is useful for detection of MMP-1. The latent form of the enzyme appears as
a doublet in the 54 kDa region of the gel, and if active forms are present,
they show up as a doublet in the 45 kDa region.
Degradation of native collagen. Rat tail collagen (4.7 mg/mL in 1 N
HCl) (BD Biosciences, Bedford, MA) was diluted to 1 mg/mL in culture
medium consisting of serum-free, Ca2þ-supplemented KBM. The collagen
solution was made isotonic by addition of an appropriate amount of 103
concentrated Hank balanced salt solution and the pH brought to 7.2. The
collagen was dispensed into glass tubes (0.5 mL/tube) for use in collagen
digestion assays. Degradation of the native collagen was achieved by
exposing it to the human skin organ culture fluid for 18 h at 378C. Intact
collagen exposed to buffer alone served as control. At the end of the
incubation period, the supernatant fluids from the control or treated collagen
were assayed. Collagen fragments released into the supernatant fluid were
resolved by SDS-PAGE (8.5% gel) and staining with Coomassie Brilliant
Blue 250-R. This procedure has been described previously (9,10).
Neutralization of MMP-1. Collagen was prepared as described above.
Organ culture fluid from UV-treated skin was used without any additional
treatment. Purified MMP-1 was activated by exposure to 1 lg/mL trypsin
for 5 min followed by inactivation of the trypsin with 10 lg soybean trypsin
inhibitor. Organ culture fluid (100 lL) and activated MMP-1 (100 ng) were
each dispensed into duplicate tubes. One tube of each pair was exposed
to the neutralizing antibody (10 lg), whereas the second tube of the pair
received buffer alone. After incubation for 15 min at 378C, 0.5 mL of the
freshly prepared collagen solution was added to each tube and incubated for
18 h at 378C. Intact collagen not exposed to either the organ culture fluid or
the purified enzyme was also incubated for 18 h as a control. At the end
of the incubation period, the supernatant fluids from the control or treated
collagen samples were removed. Collagen fragments released into the
supernatant fluid were assessed as above. Stained images were digitized and
scanned. The digitized 3
/
4 and ¼ fragments were quantified and used as
a measure of collagenolytic activity. Reduction of fragment production is
therefore a measure of enzyme neutralization.
RESULTS
Collagenolytic activity in culture fluid from UV-treated skin
In the first series of experiments, organ culture fluids prepared from
skin samples irradiated with the UVB light source were assessed
for ability to degrade intact fibrillar collagen. Shown in Fig. 1 are
results obtained with a 48 h culture fluid from one individual. In
the absence of culture fluid (lane 1), intact a1 and a2 chains of
Type-I collagen were seen. No detectable fragments were present.
Lanes 2–7 demonstrate the capacity of culture fluid from the
UV-exposed skin to degrade the intact collagen chains to produce
Figure 1. Cleavage of Type-I collagen by organ culture fluid from UV-
irradiated human skin. Lane 1 demonstrates the a1 and a2 chains of intact
Type-I collagen and the lack of 3
/
4 and ¼ fragments in the collagen stock
solution. The stock solution of collagen was separated by SDS-PAGE
before polymerization. Lanes 2–7 demonstrate the presence of 3
/
4 and ¼
fragments after exposure of the collagen substrate to decreasing amounts
(100–0.5 lL in half-log increments) of a 48 h organ culture fluid from
a UVB-exposed skin sample. (Note: The lack of significant amounts of
intact collagen in lanes 2–7 reflects the fact that most of the nondigested
collagen remains polymerized and does not enter the polyacrylamide gel.
Note that the prominent band in the middle of each lane is a protein
elaborated in the organ culture fluid).
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visible 3
/
4 and ¼ fragments. Collagen fragmentation was dose-
responsive over the range of 0.5 to 100 lL of culture fluid. The
results shown here with skin from one volunteer were represen-
tative of results from all the individuals examined.
Immunoreactive MMP-1 and MMP-13 in culture fluid
from UV-treated skin
The same culture fluids were examined by Western blotting for
reactivity with antibodies to MMP-1 and MMP-13. The results are
shown in Fig. 2. Panel A shows a representative time course for
induction of MMP-1 and MMP-13 after UV irradiation. Anti–
MMP-1 reactivity was present in the culture fluid after 24 h of
incubation but was much stronger after 48 and 72 h. Both latent
and active forms of the enzyme were detected. The presence of
active enzyme forms is not surprising, given the level of collagen-
degrading activity noted in the same culture fluids (see Fig. 1).
Panel B of Fig. 2 compares Western blot results from six subjects
(48 h postirradiation). Strong anti–MMP-1 reactivity was observed
in the organ culture fluids from all six subjects. Both active and
latent enzyme forms were present in all the culture fluids. Com-
parison of organ culture fluid from UV-irradiated human skin with
purified fibroblast-derived MMP-1 (run in varying amounts in
Western blots) indicated that in the 48 h culture fluids (the highest
enzyme levels were achieved at 48 h) the average amount of MMP-
1 in the culture fluids was 1.1 6 0.5 lg/mL, with the maximal
level being approximately 1.8 lg/mL.
In a second series of studies, three additional volunteers were
irradiated with 2 MED of light from a Solar Simulator. Their
culture fluids (48 h) were examined by Western blotting for re-
activity with antibodies to MMP-1 and MMP-13. As was seen with
the UVB light source, Solar Simulator light induced significant
upregulation of MMP-1 in these samples but did not result in
induction of MMP-13 (not shown).
MMP-1 immunoreactive bands in the 48 h culture fluids from all
nine patients (six from UVB experiment and three from the Solar
Simulator experiment) were digitized. Comparing the number
of pixels in bands from UV-treated versus control organ culture
fluid provided a way to quantify MMP-1 upregulation. The results,
Figure 2. Western blot immunoreactivity of organ culture fluid with
antibodies to MMP-1 and MMP-13. A: Varying amounts of purified MMP-
1 and MMP-13 are presented on the left. Each of the lanes on the right
contains 35 lL of organ culture fluid obtained after 24, 48 or 72 h of
incubation. The results shown in this panel were obtained with organ-
cultured skin from a single volunteer. B: Forty nanograms of purified
MMP-1 and MMP-13 are presented on the left. Lanes 1–6 contain 35 lL of
organ culture fluid from six individuals obtained after 48 h of incubation.
(Note: detectable MMP-13 immunoreactivity is present in lanes 4 and 6,
but the molecular weight of the major product [approximately 70 kDa] is
greater than that of the recombinant standard.
Figure 3. Up-regulation of MMP-1 in skin exposed to the UVB light
source or to light from the Solar Simulator. Immunoreactive bands from
48 h control and irradiated skin samples were digitized. Values obtained
with control samples from each individual were arbitrarily set at 1.0 and
values obtained after irradiation compared with this. Upper panel: UVB
light source. Lower panel: Solar Simulator. Differences between the control
and irradiated samples were compared using Student’s t-test. Values shown
for the UVB source were statistically different at the 0.01 level. Values
shown for the Solar Simulator were statistically different at the 0.07 level.
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shown in Fig. 3, indicate that MMP-1 was induced approximately
five-fold in response to UVB stimulation and 3.1-fold in response
to irradiation with the Solar Simulator. The upregulation by both
UV sources was statistically significant, but the difference between
the two light sources was not.
Assessment of organ culture fluid from UV-treated skin
by b-casein zymography and gelatin zymography
In addition to Western blotting, we also used b-casein zymography
and gelatin zymography to characterize enzyme forms present in
organ culture fluids from UVB-exposed skin samples. Figure 4
(lane 2) shows results with organ culture fluid from UV-treated
skin of one individual. It can be seen from the upper panels that
zones of b-casein hydrolysis corresponding to latent and active
forms of MMP-1 were present. Lane 1 of the same panel presents
results obtained with organ culture fluid from control human skin.
Latent MMP-1 was barely detectable, and there was no evidence
of active enzyme forms. It can be seen from the figure that enzyme
forms detectable in the b-casein zymogram comigrated with forms
in the MMP-1 Western blot. The lower panel of Fig. 4 presents
results from gelatin zymography. Consistent with past results (3,4),
organ culture fluid from UV-treated skin demonstrated signifi-
cantly increased amounts of latent and active MMP-9 (gelatinase
B) as compared with organ culture fluid from control skin. Also
consistent with past results (3), there was little difference between
UV-treated and control skin in the expression of MMP-2
(gelatinase A). MMP-13, which characteristically appears as a zone
of hydrolysis below the active form of MMP-2 (11), was not
detected in either the UV-treated or control skin organ culture
fluid.
Inhibition of collagen-degrading activity
in organ culture fluid of UV-treated human skin
Taken together, the above findings strongly suggest that MMP-1
rather than MMP-13 is responsible for most of the collagen-
degrading activity in organ culture fluid of UV-irradiated human
skin. To confirm this, organ culture fluid from three UV-treated
skin samples (100 lL/sample) was exposed for 15 min to 10 lg
of a neutralizing antibody to MMP-1. One hundred nanograms of
purified and activated MMP-1 was exposed to the same antibody
as a control. At the end of the 15 min incubation period, 0.5 mg
of intact Type-I collagen was added to the antibody-treated sam-
ples and to appropriate controls. The samples were incubated for
18 h, after which fragmentation of the intact collagen chains to 3
/
4
and ¼ fragments was assessed. Results from studies with organ
culture fluid indicated that 95 6 4% of the activity was removed
by antibody treatment (not shown). In parallel studies with
purified and activated MMP-1, 88 6 6% inhibition was achieved
(n ¼ 3).
DISCUSSION
Extensive damage to the collagenous matrix of the skin is one of
the hallmarks of photoaging. Upregulation of MMP over years or
decades by chronic or episodic exposure to UV irradiation from the
sun is thought to be the major contributor to the collagen damage
seen in photoaging (4), but the precise role of individual MMP is
not yet known. There are three collagenolytic MMP found in
human skin—MMP-1 (interstitial collagenase), MMP-8 (neutro-
phil collagenase) and MMP-13 (collagenase-3). Recent studies by
Fisher et al. (5) provided strong suggestive evidence that MMP-8 is
unlikely to play a major role in UV-mediated collagen damage in
the skin.
The present study focuses on the other two collagenases (MMP-
1 and MMP-13). Our results strongly suggest that of the two
enzymes, MMP-1 is likely to play the predominant role. MMP-1
was strongly upregulated in skin after UV exposure, whereas
MMP-13 either was not detected or was barely detected. By
comparison of organ culture fluid from UV-irradiated human skin
with purified fibroblast-derived MMP-1 in Western blots, we
estimate that in the 48 h culture fluids (the highest enzyme levels
were achieved at 48 h) MMP-1 was present at levels up to 1.8 lg/
mL. Interestingly, immunoreactive bands detected in Western
blots (as well as zymographic bands in the b-casein zymograms)
indicated that a significant proportion of the total enzyme was
present as the lower molecular weight active forms rather than as
latent forms. What accounts for MMP-1 activation in UV-exposed
skin is not known with certainty. Enzyme activation may reflect
free radical generation because oxygen free radicals are known to
be generated in human skin by UV light (12) and oxidants are
known to be potent activators of MMP (13). Alternatively, other
MMP as well as serine proteinases such as plasmin have the
capacity to activate MMP (14,15). It would be of interest to know
if one or more of these enzymes were upregulated by UV exposure.
In any event, the presence of active MMP-1 was detected in the
Day-1 culture fluid, where total MMP-1 levels were low, as well
as at the later time-points. Thus, it is likely that enzyme activation
is not simply a consequence of long-term incubation in organ
culture. It should be noted in this regard that past studies have
demonstrated the presence of active collagenolytic and gelatino-
lytic activities in UV-irradiated skin (3,4). In contrast, MMP-1
Figure 4. b-Casein and gelatin zymography of organ culture fluid from
nonirradiated and UVB-treated human skin. An MMP-1 standard is shown
at left in the b-casein zymogram. Lane 1: organ culture fluid from normal
(non-irradiated) skin. Lane 2: organ culture fluid from UV-irradiated skin
(48 h in culture). A faint, hazy band corresponding to latent MMP-1 can
be seen in lane 1 (normal skin) of the b-casein zymogram. Bands cor-
responding to latent and active forms of MMP-1 can be seen in lane 2
(UV-treated) of the b-casein zymogram. Latent and active bands in b-
casein zymography correspond to anti–MMP-1 immunoreactive bands in
Western blots (right-side panel). A combination MMP-2 and MMP-9
standard is shown at left in gelatin zymography. Bands corresponding
to MMP-9 and MMP-2 can be seen in lanes 1 and 2 of the gelatin
zymogram. Bands corresponding to both latent and active MMP-2 are
present in both lanes, and the levels are similar. A band corresponding
to latent MMP-9 is seen in lane 1, and lane 2 demonstrates bands cor-
responding to both latent and active MMP-9. MMP-9 reactivity is in-
creased in organ culture fluid from UV-treated skin as compared with
control. No band is observed immediately below the active MMP-2 band
in either lane. The results shown in this figure were obtained with organ-
cultured skin from a single volunteer. The results were consistent among
all volunteers.
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detected in organ culture fluid from normal human skin was present
in much smaller amounts and was always present as the latent form
only.
Exposure of Type-I collagen to organ culture fluid from
UV-treated skin resulted primarily in generation of the 3
/
4 and
¼ fragments. This is of interest because in addition to the
upregulation of MMP-1, UV irradiation also resulted in the
induction and activation of MMP-9 (3,4) (see Fig. 4). Because
MMP-9 effectively removes collagen fragments generated by
exposure of intact collagen to MMP-1 (10), the question arises as
to why the enzyme (MMP-9) is apparently not effective in whole
skin organ culture fluid. Two possibilities come to mind. First, it
may be a question of stoichiometry. Each a1 or a2 chain of Type-I
collagen provides a single molecule of substrate for MMP-1. In
contrast, each 3
/
4 and ¼ fragment produced by MMP-1 presents
multiple sites for cleavage by MMP-9. Thus, the effective rate
of bond cleavage would need to be much higher with MMP-9
than MMP-1 for the gelatinolytic enzyme to keep up with the
collagenase. Alternatively, the level of MMP-9 activity may be
lower in the organ culture fluid than what it appears to be from
gelatin zymography because of inhibitors present in the culture
fluid. Although tissue inhibitors of metalloproteinases (TIMP)
are not completely selective among MMP, there is a degree of
specificity. In particular, TIMP-1 has a high affinity for MMP-9
(16–18). We have already demonstrated that virtually all the MMP
inhibitor activity detected in human skin organ culture fluid is
caused by TIMP-1 (7,19). Thus, it may be that the available MMP
inhibitor is bound up with MMP-9 while leaving most of the
MMP-1 free. Additional studies will be needed to distinguish be-
tween these two possibilities, which are, in any case, not mutually
exclusive.
In recent studies, we demonstrated that when human skin
fibroblasts were incubated on an in vitro matrix consisting of
MMP-1–damaged Type-I collagen, production of Type-I procolla-
gen was reduced by as much as 80% as compared with procollagen
production on an intact collagen matrix (10). Under conditions in
which procollagen production was inhibited, it was estimated that
fragments were introduced in 30–40% of the collagen molecules.
The major degradation products were the 3
/
4 and ¼ fragments.
When exogenous MMP-9 was included in the incubation buffer
along with MMP-1, the major collagenous fragments were further
degraded and cleared. Under these conditions, loss of procollagen
synthesis was not observed. On the basis of these recent results, we
hypothesized that high molecular weight fragments of collagen
served to inhibit new collagen synthesis. The present studies, taken
in conjunction with these previous results, suggest that rather
than being an in vitro observation only, the production of high
molecular weight fragments of Type-I collagen by MMP-1 under
conditions in which they cannot be effectively cleared by MMP-9
occurs in vivo. The lack of procollagen production, which is one of
the major hallmarks of severely photodamaged skin (20,21) may
therefore reflect a response to the presence of fragmented collagen
in the severely damaged skin.
In summary, MMP-mediated collagen damage is a characteristic
feature of photodamaged human skin. Of the three collagenolytic
enzymes present in the skin, MMP-1 (interstitial collagenase) ap-
pears to be the predominant enzyme responsible for degradation of
the collagen.
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